Day One Biopharmaceuticals
Stock Forecast, Prediction & Price Target

Day One Biopharmaceuticals Financial Estimates

Day One Biopharmaceuticals Revenue Estimates

Day One Biopharmaceuticals EBITDA Estimates

Day One Biopharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $82.04M
Low: $23.56M
High: $124.13M
avg. 0%
Avg: $229.98M
Low: $75.95M
High: $343.31M
avg. 180.30%
Avg: $371.08M
Low: $122.54M
High: $553.93M
avg. 61.35%
Avg: $562.16M
Low: $185.65M
High: $839.16M
avg. 51.49%
Net Income
 
% change YoY
$-70.44M
 
N/A
$-132.17M
 
-87.63%
$-188.91M
 
-42.92%
Avg: $-201.78M
Low: $-239.31M
High: $-123.64M
avg. -6.81%
Avg: $-97.20M
Low: $-196.24M
High: $12.76M
avg. 51.82%
Avg: $32.13M
Low: $4.15M
High: $52.72M
avg. 133.06%
Avg: $144.61M
Low: $18.70M
High: $237.25M
avg. 349.99%
EBITDA
 
% change YoY
$-72.74M
 
N/A
$-146.90M
 
-101.95%
$-206.06M
 
-40.26%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.14
 
N/A
-$2.02
 
-77.19%
-$2.37
 
-17.32%
Avg: -$2.13
Low: -$3
High: -$1.55
avg. 10.07%
Avg: -$0.97
Low: -$2.46
High: $0.16
avg. 54.56%
Avg: $0.4
Low: $0.05
High: $0.66
avg. 141.60%
Avg: $1.81
Low: $0.23
High: $2.97
avg. 349.99%
Operating Expenses
 
% change YoY
$72.74M
 
N/A
$146.90M
 
101.95%
$206.06M
 
40.26%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Day One Biopharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 132.01% in 2025-2028.

We have gathered data from 9 analysts. Their low estimate is -239.31M, average is -201.78M and high is -123.64M.

What is Day One Biopharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 73.28% in 2025-2028.

We have gathered data from 9 analysts. Their low revenue estimate is $23.56M, average is $82.04M and high is $124.13M.

What is Day One Biopharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 139.05% in 2025-2028.

We have gathered data from 9 analysts. Their low earnings per share estimate is -$3, average is -$2.13 and high is $-1.55.

What is the best performing analyst?

In the last twelve months analysts have been covering Day One Biopharmaceuticals stock. The most successful analyst is Andrew Maldonado.